Group 1: Company Overview - Renqiao Asset recently conducted research on a listed company, Langzi Co., which showed varied performance among its medical beauty brands in Q1 2025, with Jingfu Medical Beauty's net profit increasing by 633.07% while other brands like Milan Baiyu and Wuhan Wuzhou experienced declines [1] - Langzi Co. aims to focus on technological innovation, customer needs, marketing channel optimization, and data governance in its medical beauty business, adhering to the philosophy of "safe medical beauty, reputation medical beauty, and quality medical beauty" without engaging in price competition [1] - The company has reduced its holdings in Ru Yuchen and accounted for the difference between the book value and the proceeds from the sale as investment income [1] Group 2: Financial Performance - In Q1, the revenue distribution among medical beauty departments was 45.14% for minimally invasive, 39.95% for dermatology, and 14.57% for surgery [1] - The sales expense ratio for medical beauty was 35.53%, with major marketing channels including local life platforms and short video platforms [1] - Online sales in the women's clothing segment increased by 14.31%, raising its revenue share to 42.62% of the women's clothing business [1]

证券代码：002612 证券简称：朗姿股份 朗姿股份有限公司 投资者关系活动记录表 3、请介绍一下公司体外产业基金医美机构收购计划 回复：公司将在满足收购条件的前提下加速推进体外医美 机构纳入合并范围。体外机构收入体内的标准主要是规范性和 成长性。近年内，医美行业的成长性被诸多企业看好，收购市 场竞争较为激烈。为提前锁定有成长潜力的医美机构，公司通 过医美产业基金前期先筛选和孵化，主要基于以下考虑：一方 面，医美行业处于成长初期，市场上可供选择的成熟机构有限， 与公司相符合的商业模式尚未建立，经营能力尚不稳定，利润 较少或不确定，若用上市公司直接收购会导致公司营业利润的 大幅波动；另一方面，医美产业基金收购的大部分医美机构尚 处于早期的不规范阶段，不具备直接收入上市公司的条件，需 要进行一段时间的合规梳理和规范运营后才能进行体内收购。 同时，公司致力于医疗美容机构管理多年，已积累了一整套较 为科学和完善的客户引流、医疗诊治、业务流程和售后服务体 系，具备了可复制的医美机构管控模式。近年来，采用"体外 培育+ 成熟后收购"模式也已得到相关行业的上市公司的普遍 接受。截至目前，公司设立的七支医美并购基金共持有 7 ...

Group 1 - The core point of the news is that Langzi Co., Ltd. plans to reduce its stake in Ruoyuchen by up to 3% within 15 trading days, following a previous cash-out of 217 million yuan, indicating a strategic move to support its expanding medical beauty business [1][4][6] - Ruoyuchen's stock price has surged by 534% over the past year, with a year-to-date increase of over 150%, prompting Langzi's decision to sell at a high point [1][4] - Langzi's investment in Ruoyuchen has yielded over 8 times returns, marking it as one of its most successful financial investments in recent years [4][6] Group 2 - Ruoyuchen, founded in 2011 and listed in September 2020, has seen a significant shift in its business structure, with traditional e-commerce operations declining while its own brand business is on the rise [4][5] - The revenue from Ruoyuchen's self-owned brands has grown from 73.97 million yuan in 2021 to approximately 263 million yuan in 2023, accounting for nearly 19.27% of total revenue [5] - The overall gross margin for Ruoyuchen reached 44.57% in 2024, with self-owned brands achieving a gross margin of 67%, significantly higher than its other business segments [5] Group 3 - Langzi's medical beauty business has become its main revenue driver, contributing 2.784 billion yuan in 2024, which is 48.92% of total revenue, surpassing its fashion women's wear segment [9][10] - Despite the growth, the gross margin for the medical beauty segment is only 54.42%, which is lower than the 63.45% margin for the women's wear segment [9][10] - Langzi's short-term borrowings have surged by 92.11% year-on-year, indicating increasing financial pressure as it expands its medical beauty operations [9][14] Group 4 - Langzi has faced compliance issues within its medical beauty operations, with several institutions under its umbrella encountering penalties for various violations [13] - The company is actively seeking funding to support its medical beauty expansion, which may include repaying upcoming debts and acquiring regional medical beauty institutions [13][14] - The medical beauty market in China has significant growth potential, with a penetration rate of only 3%-5%, compared to 20% in South Korea, but faces challenges from competitors and macroeconomic fluctuations [13][14]

01 一门生意，交易双方都苦不堪言 在2万亿规模的中国服饰行业，女装真是让人既爱又恨。 时尚消费本该换取的是愉悦体验，但现在消费者吐槽最多的是货不对版，衣服越来越难买。审美更是全网统一，上衣短到像童装，阔腿裤长到能拖地。 任凭算法千人千面，供给恨不能千人一衣。 商家的心情也没好到哪里去。女装电商持续攀升的退货率、头部商家关店跑路的消息，都侧面印证了这个行业内卷之烈、生存之艰。 「赚钱赚得太累了，每天把自己耗死在上面。」一家全年GMV上亿的女装商家曾对《降噪NoNoise》大吐苦水。 一门生意，若交易双方都苦不堪言，必然是商业模式出了问题。 ▲图源：波士顿咨询 当未来市场增量有限，在存量中寻找结构性机会，必然伴随行业失序、疯狂内卷和残酷出清，然后是一部分商家率先找到出口，另一部分商家则永久地成 为炮灰。 女装行业的出路在哪里？那些在内卷中依然活得不错的品牌或许有发言权。 在北京大学国家发展研究院新近发布的一份《全球品牌中国线上500强》榜单中，我们发现，在苹果、华为、小米以及一众国际美妆大牌之外，还有超过 百个鞋服品牌的身影。 包括这名商家在内的从业者不是没有看到症结所在。比如之前让他倍感焦虑的抄版问题——如果 ...

Core Insights - The women's clothing market is experiencing significant growth driven by changing consumer preferences, with a focus on self-expression and individuality through fashion [1] - The rise of "fast fashion" is evident, with over 5 million new items launched daily in the spring season, indicating strong consumer demand for new styles [1] - Innovative marketing strategies, such as "topic + product" in live streaming, have led to a 487% year-on-year increase in short video sales and a peak 253% month-on-month growth in live sales [1] Market Dynamics - Rural areas, particularly in county regions, represent the largest consumer base, highlighting the potential of lower-tier markets for further investment [1] - The market faces challenges, including a significant disparity in content creator and merchant distribution, with a pronounced "strong East, weak West" pattern influenced by supply chain and logistics factors [1] - Product homogeneity is a major issue, leading to decreased brand differentiation, intensified price competition, and declining consumer loyalty [1] Strategic Recommendations - To enhance the development of the women's clothing market, collaboration and innovation among various stakeholders are essential [2] - Platforms should leverage their resource allocation capabilities to support merchants in underdeveloped regions through measures like traffic allocation and logistics subsidies [2] - Merchants need to analyze consumer trends regarding style, fabric quality, and continuously innovate their products and marketing strategies to create appealing and wearable clothing [2]

Group 1 - The core concept of "White Piao Economics" is that in certain industries, the cost of supervision exceeds the benefits, leading to opportunities for exploitation [3][15][39] - In the hotel industry, the practice of checking for missing items upon checkout has largely disappeared due to the high cost of supervision compared to the value of lost items [5][6][9] - E-commerce's no-reason refund policy was widely accepted when the market was large enough to absorb the costs associated with a small number of exploitative customers [10][11][12] Group 2 - The increase in the proportion of exploitative customers in recent years has made it difficult for businesses to sustain their operations, leading to price increases or withdrawal from the market [16][38] - The dynamics of customer behavior have shifted, with more demanding customers concentrated in specific segments, such as female passengers choosing female drivers, which has increased the pressure on service providers [19][20][22] - The gaming industry also reflects this model, where the vocal minority can disproportionately influence the market, leading to a situation where the support base for certain products becomes unsustainable [28][34][36]

Core Insights - The company reported a revenue of 3.036 billion yuan for the year 2024, reflecting a year-on-year growth of 4% [1] - In Q1 2025, the company achieved a revenue of 690 million yuan, with a net profit attributable to shareholders of 40 million yuan, marking a 40% year-on-year increase [1] Business Performance - The company's brands, including ELLASSAY, Laurèl, IRO China, and self-portrait, showed strong sales growth in 2024, with increases of 8%, 19%, 17%, and 21% respectively [1] - In Q1 2025, the international brands continued to perform well in the domestic market, with self-portrait, Laurèl, and IRO China growing by 17%, 13%, and 14% respectively, while ELLASSAY remained stable [1] Online Sales Growth - Online sales grew by 32% in 2024, with significant contributions from platforms like Douyin, Xiaohongshu, and Tmall [2] - In Q1 2025, online sales on a comparable basis increased by 26%, with online sales accounting for 18% of total sales, up 4.1 percentage points from the previous year [2] Store Expansion and Market Position - The company added 27 new stores in 2024, expanding its presence in key cities such as Macau, Shenzhen, Nanjing, and Hangzhou [2] - The multi-brand and multi-platform strategy has begun to yield results, enhancing the brand matrix's collaborative capabilities and solidifying the company's competitive position in the mid-to-high-end women's wear market [2] Shareholder Value - The company has consistently returned value to shareholders since its listing, proposing a cash dividend of 18.1867 million yuan for the year 2024 [2]

Core Viewpoint - In the first quarter of 2025, Langzi Co., Ltd. experienced a decline in overall revenue but showed improvements in net profit and gross margin in certain business segments [2][3]. Financial Performance Summary - The total revenue for the first quarter of 2025 was approximately 1.399 billion yuan, a year-on-year decrease of 7.77% [2]. - The gross margin was 59.72%, an increase of 0.61 percentage points compared to the same period last year [2]. - The net profit attributable to shareholders was about 95 million yuan, up 5.12% year-on-year [2]. - The net cash flow from operating activities was approximately 174 million yuan, down 23.43% year-on-year [2]. - Basic earnings per share were 0.2153 yuan, an increase of 5.13% year-on-year [2]. - As of March 31, 2025, total assets were approximately 8.004 billion yuan, a 0.41% increase from the end of the previous year [2]. Business Segment Performance - **Medical Aesthetics Segment**: Revenue was approximately 670 million yuan, a decrease of 9.22% year-on-year; gross profit was about 369 million yuan, down 8.58% year-on-year; net profit attributable to shareholders was approximately 38.21 million yuan, a decrease of 36.94% [3]. - **Women's Clothing Segment**: Revenue was approximately 504 million yuan, a decrease of 5.74% year-on-year; gross profit was about 325 million yuan, down 5.52% year-on-year; net profit attributable to shareholders was approximately 36.63 million yuan, an increase of 21.21% [3]. - **Infant and Child Segment**: Revenue was approximately 221 million yuan, a decrease of 8.52% year-on-year; gross profit was about 137 million yuan, with a gross margin of 62.28%, up 1.78% year-on-year; net profit was 492,800 yuan, down 72.23% [3]. Investor Communication Insights - Various medical aesthetics brands showed mixed performance in Q1 2025, with Milan Baiyu's revenue decreasing by 8.74% to approximately 302.62 million yuan, while Jingfu Medical's revenue increased by 1.13% to approximately 125.20 million yuan [4]. - The company operated 41 medical aesthetics institutions as of the end of Q1 2025, including 12 comprehensive hospitals and 29 outpatient departments and clinics [4]. - The total inventory for the women's clothing segment was approximately 646 million yuan, a decrease of 4.75% from the end of the previous year, indicating improved inventory structure [4].

Financial Performance - In Q1 2025, the company achieved total revenue of approximately 1.399 billion yuan, a year-on-year decrease of 7.77% [2] - Gross profit margin was 59.72%, an increase of 0.38 percentage points compared to the same period last year [2] - Net profit attributable to shareholders was approximately 61 million yuan, a year-on-year increase of 5.12% [2] - Net profit after deducting non-recurring items was approximately 73 million yuan, a year-on-year decrease of 6.89% [2] - Net cash flow from operating activities was approximately 174 million yuan, a year-on-year decrease of 23.43% [2] - Basic earnings per share were 0.2153 yuan, an increase of 5.13% year-on-year [2] - Return on equity was 3.36% [2] - As of March 31, 2025, total assets were approximately 8.004 billion yuan, a growth of 0.41% from the end of the previous year [3] - Net assets attributable to shareholders were approximately 2.883 billion yuan, an increase of 3.42% from the end of the previous year [3] Business Segment Performance - Medical beauty segment revenue was approximately 670 million yuan, a year-on-year decrease of 9.22% [3] - Medical beauty segment gross profit was approximately 369 million yuan, a decrease of 8.58% year-on-year, with a gross profit margin of 55.05% [3] - Women's clothing segment revenue was approximately 504 million yuan, a year-on-year decrease of 5.74% [3] - Women's clothing segment gross profit was approximately 325 million yuan, with a gross profit margin of 64.51%, an increase of 0.15 percentage points year-on-year [3] - Infant and child segment revenue was approximately 221 million yuan, a year-on-year decrease of 8.52% [3] - Infant and child segment gross profit was approximately 137 million yuan, with a gross profit margin of 62.28%, an increase of 1.78 percentage points year-on-year [3] Brand Performance - Milan Baiyu achieved revenue of approximately 302.62 million yuan, a year-on-year decrease of 8.74% [4] - Jingfu Medical achieved revenue of approximately 125.20 million yuan, a year-on-year increase of 1.13% [4] - Hanchen Medical achieved revenue of approximately 97.93 million yuan, a year-on-year decrease of 1.43% [4] - Wuhan Wuzhou achieved revenue of approximately 47.55 million yuan, a year-on-year decrease of 15.11% [4] - Changsha Yamei achieved revenue of approximately 40.70 million yuan, a year-on-year decrease of 28.61% [4] - Zhengzhou Jimei achieved revenue of approximately 25.68 million yuan, a year-on-year decrease of 16.26% [4] Inventory and Operations - As of Q1 2025, total inventory for women's clothing was approximately 646 million yuan, a decrease of 4.75% from the end of the previous year [5] - The net amount of inventory goods was approximately 512 million yuan, a decrease of 7.45% from the end of the previous year [5] - The structure of inventory improved in Q1 2025 [5]

2024年，欣贺股份在女装行业的寒冬中遭遇滑铁卢。报告显示，公司2024年营业收入为14.05亿元，同 比下降20.10%；归母净利润为-6737.81万元，同比下降167.29%；扣非归母净利润为-7702.58万元，同比 下降192.48%；基本每股收益-0.16元。 这家以JORYA、ΛNMΛNI等高端女装品牌闻名的企业，创下上市以来最大亏损纪录。从表面看，业绩 下滑源于消费疲软与战略调整的阵痛，但深层次暴露的是品牌定位摇摆、运营效率低下与成本结构失衡 等系统性风险。曾经的高端女装标杆，正陷入转型方向与执行能力的双重考验。 战略调整的阵痛：品牌定位模糊与渠道收缩反噬 销售费用率高达54.36% 欣贺股份的亏损并非偶然，而是战略转型过程中资源配置失当的必然结果。2023年底启动的品牌定位升 级，试图通过产品线调整、渠道焕新重塑品牌形象，但执行层面暴露出三大矛盾： 2024年，公司经营活动现金流同比骤降66.41%，显示主营业务造血能力衰竭。这种"高库存、低周转"的 恶性循环，使得公司即便拥有67%的毛利率，也难以抵挡净利润的断崖式下跌。 品牌定位的进退失据。公司将JORYA等主品牌向年轻化、轻奢化方向调整 ...